During the past decade, Northeast Indiana Research, LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 12 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast Indiana Research, LLC" #1 sponsor was "Endo Pharmaceuticals" with 4 trials, followed by "Ferring Pharmaceuticals" with 4 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "AEterna Zentaris" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Indiana Research, LLC" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Biotronik, Inc." with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "King Pharmaceuticals is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Scripps Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Indiana Research, LLC" are "Prostate Cancer" (6 trials), "Benign Prostatic Hypertrophy" (3 trials), "Coronary Artery Disease" (3 trials), "Peyronie's Disease" (3 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Northeast Indiana Research, LLC" in a lesser frequency.

Most popular intervention types in "Northeast Indiana Research, LLC" are "Drug" (21 trials), "Device" (8 trials), "Biological" (5 trials), "Procedure" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Degarelix" (4 trials), "AA4500" (3 trials), "Androxal" (2 trials) and "ACUITY Spiral Left Ventricular Lead" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Indiana Research, LLC" are 20 trials for "Male" genders, 12 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Northeast Indiana Research, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Northeast Indiana Research, LLC, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Indiana Research, LLC, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".